4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0000950170-24-012456
Chief Medical Officer sold 24,552 shares at $30.05 ($737,788)
- Chief Medical Officer acquired 24,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kim Robert Young Chief Medical Officer | 2024-02-05 | Option exercise 10b5-1 | +12,000 | $18.66 | $223,920 | 13,595 | D |
| Kim Robert Young Chief Medical Officer | 2024-02-05 | Sale 10b5-1 | −12,000 | $30.05 | $360,600 | 1,595 | D |
| Kim Robert Young Chief Medical Officer | 2024-02-05 | Option exercise 10b5-1 | +6,000 | $15.78 | $94,680 | 7,595 | D |
| Kim Robert Young Chief Medical Officer | 2024-02-05 | Sale 10b5-1 | −6,000 | $30.05 | $180,300 | 1,595 | D |
| Kim Robert Young Chief Medical Officer | 2024-02-05 | Option exercise 10b5-1 | +6,000 | $8.04 | $48,240 | 7,595 | D |
| Kim Robert Young Chief Medical Officer | 2024-02-05 | Sale 10b5-1 | −6,000 | $30.05 | $180,300 | 1,595 | D |
| Kim Robert Young Chief Medical Officer | 2024-02-05 | Sale 10b5-1 | −552 | $30.05 | $16,588 | 1,043 | D |
| Derivatives | |||||||
| Kim Robert Young Chief Medical Officer | 2024-02-05 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,000 | 138,000 | D | ||
| Kim Robert Young Chief Medical Officer | 2024-02-05 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,000 | 64,000 | D | ||
| Kim Robert Young Chief Medical Officer | 2024-02-05 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,000 | 54,000 | D | ||
| Open-market sales · 24,552 sh · avg $30.05 · $737,788 | |||||||
Loading xslF345X05/ownership.xml…